<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000546733"><TermName>CDK inhibitor AT7519M</TermName><TermPronunciation>(... in-HIH-bih-ter ...)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of cancer. CDK inhibitor AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called AT7519M.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718788" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CDK inhibitor AT7519M&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718789" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor AT7519M de la CDC&quot;" language="es" id="_4"/><SpanishTermName>inhibidor AT7519M de la CDC</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de cáncer. El inhibidor AT7519M de la CDC bloquea las enzimas que las células necesitan para dividirse. Es un tipo de inhibidor de la cinasa dependiente de la ciclina. También se llama AT7519M.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-05-04</DateFirstPublished></GlossaryTerm>
